Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   MEDICAL JOURNAL OF THE ISLAMIC REPUBLIC OF IRAN (MJIRI)   2018 , Volume 32 , Number 1; Page(s) 0 To 0.

Molecular prevalence of parvovirus B19 among HIV1-infected patients in Iran



Author(s):  Kiani Seyed Jalal, Javanmard Davod, GHAFFARI HADI, TAVAKOLI AHMAD, Mortazavi Helya Sadat, BOKHARAEI SALIM FARAH, Bangaleh Zahra, MONAVARI SEYED HAMIDREZA*
* Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
Background: Different outcomes of parvovirus B19 (B19V) infection in immunocompromised patients, including HIV1-infected persons, may be life-threatening. Considering the hematologic disorders associated with B19V infection, this study aimed to investigate the prevalence of B19V infection among HIV1-infected individuals in Iran. Methods: Serum samples from 100 HIV1-infected patients were analyzed for B19 viral DNA using real-time PCR assay. COBAS TaqMan HIV-1 test was performed for quantitative measurements of HIV-1 RNA in the patients’ sera. Results: Real-time PCR analysis revealed that 10 out of 100 cases (10%) were positive for B19V infection. Across various age groups, the B19V infection was more prevalent among patients within the age range of 21-40 years. Higher prevalence of B19V infection was observed among HIV1-infected patients with a viral load of higher than 400 copies/mL. Conclusion: Despite limitations, this study may set the stage for further evaluations with larger sample sizes to elucidate the potential role of B19V in hematologic disorders, which may result in exacerbation of the disease in HIV1-infected patients. Moreover, as it has been shown that B19V infection can be treated using intravenous immunoglobulin (IVIG) therapy, available treatments may help improve the quality of life in HIV-infected persons.
Keyword(s): Parvovirus B19,HIV-1,Anemia,AIDS
  pdf-File tarjomyar Yearly Visit 46
Latest on Blog
Enter SID Blog